MacroGenics
MGNX
#9145
Rank
A$0.16 B
Marketcap
A$2.63
Share price
-5.18%
Change (1 day)
-43.23%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: A$0.16 Billion

As of February 2026 MacroGenics has a market cap of A$0.16 Billion. This makes MacroGenics the world's 9145th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.16 B9.55%
2025A$0.15 B-53.35%
2024A$0.32 B-62.79%
2023A$0.87 B44.49%
2022A$0.60 B-55.34%
2021A$1.35 B-18.83%
2020A$1.67 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of MacroGenics was reported to be:

A$0.16 Billion
by Nasdaq info icon info icon
A$0.16 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$216.32 B 129,760.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.337 T 803,057.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$264.91 B 158,927.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$253.45 B 152,049.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$396.34 B 237,826.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$161.26 B 96,708.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$1.24 B 645.79%๐Ÿ‡บ๐Ÿ‡ธ USA